{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:10:05Z","timestamp":1793736605511,"version":"4.6.1"},"reference-count":137,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100005709","name":"Endocrine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005709","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Primary aldosteronism (PA) is a leading endocrine cause of secondary hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To support the development of the Endocrine Society Clinical Practice Guideline on managing PA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Source<\/jats:title>\n                    <jats:p>MEDLINE, Embase, Scopus, and others were searched on October 4, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection<\/jats:title>\n                    <jats:p>Studies were selected by pairs of independent reviewers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction<\/jats:title>\n                    <jats:p>Data were extracted and appraised by pairs of independent reviewers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis<\/jats:title>\n                    <jats:p>We included 95 studies (7 randomized trials and 88 observational studies). We did not identify trials that evaluated the outcomes of PA screening. One observational study suggested that screening was associated with higher rates of using PA-specific medical therapies and better blood pressure control. Patients managed with adrenal venous sampling (vs computed tomography alone) may have a better post-adrenalectomy biochemical cure rate, but with an increased risk of adrenal hemorrhage. Two small observational studies suggested that PA-specific medical or surgical therapy was likely associated with better blood pressure control than nonspecific therapy. Small randomized trials suggested that surgical therapy may be associated with better blood pressure control than medical therapy, with a lower number and dosage of antihypertensive medications. Compared to eplerenone, spironolactone may be associated with better control of hypokalemia and a lower number and dosage of antihypertensive agents. Unsuppressed plasma renin activity was associated with better control of hypokalemia, while suppression was associated with higher risk of mortality, atrial fibrillation, and stroke (very low certainty).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This systematic review addresses various aspects of managing PA and will support the development of the Endocrine Society guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf290","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:58:55Z","timestamp":1747295935000},"page":"e2833-e2844","source":"Crossref","is-referenced-by-count":29,"title":["A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on Management of Primary Aldosteronism"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-737X","authenticated-orcid":false,"given":"Magdoleen H","family":"Farah","sequence":"first","affiliation":[{"name":"Evidence-Based Practice Research Program, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa","family":"Hegazi","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Research Program, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Firwana","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Research Program, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abusalih","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Research Program, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Saadi","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Research Program, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al-Kordi","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Research Program, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Elsheikh","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, University of Colorado , Denver, CO 80045 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Research Program, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Hassett","sequence":"additional","affiliation":[{"name":"Mayo Clinic Libraries, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-2524","authenticated-orcid":false,"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-5975","authenticated-orcid":false,"given":"M Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Research Program, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"14","key":"2025081215532457800_dgaf290-B1","doi-asserted-by":"crossref","first-page":"e025952","DOI":"10.1161\/JAHA.122.025952","article-title":"Primary aldosteronism screening rates differ with sex, race, and comorbidities","volume":"11","author":"Turcu","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"2025081215532457800_dgaf290-B2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2025081215532457800_dgaf290-B3","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians in Europe","volume":"34","author":"Mulatero","year":"2016","journal-title":"J Hypertens"},{"issue":"8","key":"2025081215532457800_dgaf290-B4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"issue":"11","key":"2025081215532457800_dgaf290-B5","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2025081215532457800_dgaf290-B6","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025081215532457800_dgaf290-B7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"Buffolo","year":"2017","journal-title":"Horm Metab Res"},{"issue":"2","key":"2025081215532457800_dgaf290-B8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/HJH.0000000000002250","article-title":"Atrial fibrillation as presenting sign of primary aldosteronism: results of the prospective appraisal on the prevalence of primary aldosteronism in hypertensive (PAPPHY) study","volume":"38","author":"Seccia","year":"2020","journal-title":"J Hypertens"},{"issue":"4","key":"2025081215532457800_dgaf290-B9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"issue":"8","key":"2025081215532457800_dgaf290-B10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1507\/endocrj.EJ13-0060","article-title":"Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus and hypertension","volume":"60","author":"Murase","year":"2013","journal-title":"Endocr J"},{"issue":"4","key":"2025081215532457800_dgaf290-B11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1210\/clinem\/dgz293","article-title":"Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes and hypertension","volume":"105","author":"Hu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025081215532457800_dgaf290-B12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41371-020-0336-2","article-title":"Primary aldosteronism is a public health issue: challenges and opportunities","volume":"34","author":"Libianto","year":"2020","journal-title":"J Hum Hypertens"},{"key":"2025081215532457800_dgaf290-B13","author":"Primary Aldosteronism Foundation"},{"issue":"10060","key":"2025081215532457800_dgaf290-B14","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","article-title":"A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet commission on hypertension","volume":"388","author":"Olsen","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"2025081215532457800_dgaf290-B15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2025081215532457800_dgaf290-B16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-21-0836","article-title":"Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments","volume":"186","author":"Wu","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2025081215532457800_dgaf290-B17","doi-asserted-by":"crossref","first-page":"bvae109","DOI":"10.1210\/jendso\/bvae109","article-title":"Challenges in diagnosing and managing the spectrum of primary aldosteronism","volume":"8","author":"Yang","year":"2024","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025081215532457800_dgaf290-B18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/2359-3997000000274","article-title":"Diagnosis and management of primary aldosteronism","volume":"61","author":"Vilela","year":"2017","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"2025081215532457800_dgaf290-B19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/HYPERTENSIONAHA.123.21965","article-title":"Diagnostic delay and disease burden in primary aldosteronism: an international patient survey","volume":"81","author":"Ananda","year":"2024","journal-title":"Hypertension"},{"issue":"10","key":"2025081215532457800_dgaf290-B20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/HJH.0000000000003513","article-title":"Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis","volume":"41","author":"Woode","year":"2023","journal-title":"J Hypertens"},{"key":"2025081215532457800_dgaf290-B21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IBPC.S13783","article-title":"Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine","volume":"6","author":"Funder","year":"2013","journal-title":"Integr Blood Press Control"},{"key":"2025081215532457800_dgaf290-B22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinimag.2023.04.002","article-title":"Contrast medium free selective adrenal vein sampling in the management of primary aldosteronism","volume":"99","author":"Boschheidgen","year":"2023","journal-title":"Clin Imaging"},{"issue":"1","key":"2025081215532457800_dgaf290-B23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/HYPERTENSIONAHA.117.09294","article-title":"Adrenal vein sampling is the preferred method to select patients with primary aldosteronism for adrenalectomy: con Side of the argument","volume":"71","author":"Deinum","year":"2018","journal-title":"Hypertension"},{"issue":"9","key":"2025081215532457800_dgaf290-B24","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.124.22642","article-title":"Clinical management of primary aldosteronism: an update","volume":"81","author":"Rossi","year":"2024","journal-title":"Hypertension"},{"issue":"1","key":"2025081215532457800_dgaf290-B25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/endrev\/bnad024","article-title":"Biomarkers to guide medical therapy in primary aldosteronism","volume":"45","author":"Hundemer","year":"2024","journal-title":"Endocr Rev"},{"issue":"Suppl 1","key":"2025081215532457800_dgaf290-B26","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1097\/01.hjh.0001022476.03102.63","article-title":"Feasibility of subtyping of primary aldosteronism by adrenal vein sampling during mineralocorticoid receptor antagonist treatment","volume":"42","author":"Pintus","year":"2024","journal-title":"J Hypertens"},{"issue":"1","key":"2025081215532457800_dgaf290-B27","doi-asserted-by":"crossref","first-page":"21722","DOI":"10.1038\/s41598-023-47967-z","article-title":"Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study","volume":"13","author":"Kitamoto","year":"2023","journal-title":"Sci Rep"},{"key":"2025081215532457800_dgaf290-B28","doi-asserted-by":"crossref","first-page":"797021","DOI":"10.3389\/fendo.2022.797021","article-title":"Recent advances in the clinical application of adrenal vein sampling","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2025081215532457800_dgaf290-B29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajh\/hpac079","article-title":"Primary aldosteronism: state-of-the-art review","volume":"35","author":"Vaidya","year":"2022","journal-title":"Am J Hypertens"},{"issue":"3","key":"2025081215532457800_dgaf290-B30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2007-970409","article-title":"Detecting and treating primary aldosteronism: primary aldosteronism","volume":"115","author":"Mantero","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"2025081215532457800_dgaf290-B31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025081215532457800_dgaf290-B32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.31128\/AJGP-05-18-4587","article-title":"Current pattern of primary aldosteronism diagnosis: delayed and complicated","volume":"47","author":"Lim","year":"2018","journal-title":"Aust J Gen Pract"},{"issue":"3","key":"2025081215532457800_dgaf290-B33","doi-asserted-by":"crossref","first-page":"e1280","DOI":"10.1210\/clinem\/dgad654","article-title":"Time to benefit of surgery vs targeted medical therapy for patients with primary aldosteronism: a meta-analysis","volume":"109","author":"Samnani","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081215532457800_dgaf290-B34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-med-042921-100438","article-title":"Primary aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys","volume":"74","author":"Cohen","year":"2023","journal-title":"Annu Rev Med"},{"issue":"3","key":"2025081215532457800_dgaf290-B35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12020-022-03029-4","article-title":"Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO registry","volume":"76","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"issue":"2","key":"2025081215532457800_dgaf290-B36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12020-022-03122-8","article-title":"Adrenal venous sampling in primary aldosteronism: experience of a Spanish multicentric study (results from the SPAIN-ALDO register)","volume":"78","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"issue":"3","key":"2025081215532457800_dgaf290-B37","doi-asserted-by":"crossref","first-page":"e13419","DOI":"10.1111\/eci.13419","article-title":"Quality of life in primary aldosteronism: a prospective observational study","volume":"51","author":"Buffolo","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2025081215532457800_dgaf290-B38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"2025081215532457800_dgaf290-B39","unstructured":"Farah M, Hegazi M, Firwana M, et al \u00a0Supplemental Material for a Systematic review supporting the Endocrine society clinical practice guideline on management of primary aldosteronism. figshare."},{"key":"2025081215532457800_dgaf290-B40","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025081215532457800_dgaf290-B41","first-page":"603","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of case-control studies in meta-analyses","volume":"25","author":"Wells","year":"2011","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"2025081215532457800_dgaf290-B42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"2025081215532457800_dgaf290-B43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans: a retrospective cohort study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025081215532457800_dgaf290-B44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-12-0631","article-title":"Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism","volume":"168","author":"Fourkiotis","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025081215532457800_dgaf290-B45","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.116.07214","article-title":"Suppression of aldosterone secretion after recumbent saline infusion does not exclude lateralized primary aldosteronism","volume":"68","author":"Cornu","year":"2016","journal-title":"Hypertension"},{"key":"2025081215532457800_dgaf290-B46","doi-asserted-by":"crossref","first-page":"916744","DOI":"10.3389\/fendo.2022.916744","article-title":"Treatment of primary aldosteronism and reversal of renin suppression improves left ventricular systolic function","volume":"13","author":"Puar","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025081215532457800_dgaf290-B47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025081215532457800_dgaf290-B48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"2025081215532457800_dgaf290-B49","doi-asserted-by":"crossref","first-page":"e2338209","DOI":"10.1001\/jamanetworkopen.2023.38209","article-title":"Corticotropin stimulation in adrenal venous sampling for patients with primary aldosteronism: the ADOPA randomized clinical trial","volume":"6","author":"Yang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025081215532457800_dgaf290-B50","doi-asserted-by":"crossref","first-page":"20406223221143233","DOI":"10.1177\/20406223221143233","article-title":"Mineralocorticoid receptor antagonist treatment improved arterial stiffness in patients with primary aldosteronism: a cohort study compared with adrenalectomy","volume":"14","author":"Liao","year":"2023","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"2025081215532457800_dgaf290-B51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","article-title":"[(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial","volume":"29","author":"Wu","year":"2023","journal-title":"Nat Med"},{"issue":"4","key":"2025081215532457800_dgaf290-B52","doi-asserted-by":"crossref","first-page":"e028146","DOI":"10.1161\/JAHA.122.028146","article-title":"Markers of kidney tubular function deteriorate while those of kidney tubule health improve in primary aldosteronism after targeted treatments","volume":"12","author":"Wu","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2025081215532457800_dgaf290-B53","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/clinem\/dgac649","article-title":"Implication of MR activity in posttreatment arterial stiffness reversal in patients with primary aldosteronism","volume":"108","author":"Chen","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025081215532457800_dgaf290-B54","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/HJH.0000000000003135","article-title":"Persistent cardiac organ damage in surgically and medically treated primary aldosteronism","volume":"40","author":"Aune","year":"2022","journal-title":"J Hypertens"},{"key":"2025081215532457800_dgaf290-B55","doi-asserted-by":"crossref","first-page":"770711","DOI":"10.3389\/fendo.2021.770711","article-title":"A prospective comparative study on cardiac alterations after surgery and drug treatment of primary aldosteronism","volume":"12","author":"Chen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2025081215532457800_dgaf290-B56","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-21-0018","article-title":"Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study","volume":"185","author":"Kohler","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025081215532457800_dgaf290-B57","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/HYPERTENSIONAHA.120.16909","article-title":"Time-dependent risk of atrial fibrillation in patients with primary aldosteronism after medical or surgical treatment initiation","volume":"77","author":"Kim","year":"2021","journal-title":"Hypertension"},{"issue":"5","key":"2025081215532457800_dgaf290-B58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eprac.2020.10.007","article-title":"Prevalence, subtype classification, and outcomes of treatment of primary aldosteronism: a prospective study in China","volume":"27","author":"Xu","year":"2021","journal-title":"Endocr Pract"},{"key":"2025081215532457800_dgaf290-B59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2021.03.033","article-title":"Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism","volume":"324","author":"Haze","year":"2021","journal-title":"Atherosclerosis"},{"issue":"1","key":"2025081215532457800_dgaf290-B60","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1038\/s41598-021-86290-3","article-title":"Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism","volume":"11","author":"Nakamaru","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"2025081215532457800_dgaf290-B61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cen.14351","article-title":"Outcomes in unilateral primary aldosteronism after surgical or medical therapy","volume":"94","author":"Puar","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2025081215532457800_dgaf290-B62","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ekir.2020.06.012","article-title":"Associations between changes in plasma renin activity and aldosterone concentrations and changes in kidney function after treatment for primary aldosteronism","volume":"5","author":"Kobayashi","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"4","key":"2025081215532457800_dgaf290-B63","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3803\/EnM.2020.797","article-title":"Changes in glucose metabolism after adrenalectomy or treatment with a mineralocorticoid receptor antagonist for primary aldosteronism","volume":"35","author":"Lin","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6","key":"2025081215532457800_dgaf290-B64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/EJE-20-0532","article-title":"Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism","volume":"183","author":"Soinio","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"16","key":"2025081215532457800_dgaf290-B65","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2025081215532457800_dgaf290-B66","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/HYPERTENSIONAHA.119.14601","article-title":"Nadir aldosterone levels after confirmatory tests are correlated with left ventricular hypertrophy in primary aldosteronism","volume":"75","author":"Ohno","year":"2020","journal-title":"Hypertension"},{"issue":"5","key":"2025081215532457800_dgaf290-B67","doi-asserted-by":"crossref","first-page":"e013699","DOI":"10.1161\/JAHA.119.013699","article-title":"Influence of different treatment strategies on new-onset atrial fibrillation among patients with primary aldosteronism: a nationwide longitudinal cohort-based study","volume":"9","author":"Pan","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2025081215532457800_dgaf290-B68","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"issue":"7","key":"2025081215532457800_dgaf290-B69","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/HJH.0000000000002070","article-title":"Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism","volume":"37","author":"Katabami","year":"2019","journal-title":"J Hypertens"},{"key":"2025081215532457800_dgaf290-B70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jss.2018.10.040","article-title":"Treatment of primary aldosteronism reduces the probability of obstructive sleep apnea","volume":"236","author":"Wang","year":"2019","journal-title":"J Surg Res"},{"issue":"8","key":"2025081215532457800_dgaf290-B71","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"3","key":"2025081215532457800_dgaf290-B72","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"issue":"6","key":"2025081215532457800_dgaf290-B73","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1507\/endocrj.EJ16-0530","article-title":"Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism","volume":"64","author":"Park","year":"2017","journal-title":"Endocr J"},{"key":"2025081215532457800_dgaf290-B74","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"2025081215532457800_dgaf290-B75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1507\/endocrj.EJ15-0362","article-title":"Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism","volume":"63","author":"Matsuda","year":"2016","journal-title":"Endocr J"},{"issue":"4","key":"2025081215532457800_dgaf290-B76","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/HJH.0000000000000464","article-title":"Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness","volume":"33","author":"Holaj","year":"2015","journal-title":"J Hypertens"},{"issue":"4","key":"2025081215532457800_dgaf290-B77","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/1470320314549220","article-title":"Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism","volume":"16","author":"Indra","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"7","key":"2025081215532457800_dgaf290-B78","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00268-014-2461-y","article-title":"Is adrenal venous sampling mandatory before surgical decision in case of primary hyperaldosteronism?","volume":"38","author":"Pirvu","year":"2014","journal-title":"World J Surg"},{"issue":"5","key":"2025081215532457800_dgaf290-B79","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025081215532457800_dgaf290-B80","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"issue":"7","key":"2025081215532457800_dgaf290-B81","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1245\/s10434-013-2871-3","article-title":"Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes","volume":"20","author":"Kline","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2025081215532457800_dgaf290-B82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14310\/horm.2002.1342","article-title":"Adrenal venous sampling as a diagnostic procedure for primary hyperaldosteronism: experience from a tertiary referral centre","volume":"11","author":"Salem","year":"2012","journal-title":"Hormones (Athens)"},{"issue":"3","key":"2025081215532457800_dgaf290-B83","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0032-1301902","article-title":"Predictive factors of left ventricular mass changes after treatment of primary aldosteronism","volume":"44","author":"Catena","year":"2012","journal-title":"Horm Metab Res"},{"issue":"3","key":"2025081215532457800_dgaf290-B84","first-page":"274","article-title":"Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment","volume":"35","author":"Bernini","year":"2012","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"2025081215532457800_dgaf290-B85","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025081215532457800_dgaf290-B86","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment","volume":"94","author":"Sechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025081215532457800_dgaf290-B87","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajh.2008.243","article-title":"Adrenalectomy improves arterial stiffness in primary aldosteronism","volume":"21","author":"Strauch","year":"2008","journal-title":"Am J Hypertens"},{"issue":"5","key":"2025081215532457800_dgaf290-B88","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"2025081215532457800_dgaf290-B89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"issue":"5","key":"2025081215532457800_dgaf290-B90","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","article-title":"Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome","volume":"141","author":"Nwariaku","year":"2006","journal-title":"Arch Surg"},{"issue":"1","key":"2025081215532457800_dgaf290-B91","first-page":"21","article-title":"Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment","volume":"108","author":"Sindelka","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"2025081215532457800_dgaf290-B92","first-page":"337","article-title":"Long-term results of surgical and conservative treatment of patients with primary aldosteronism","volume":"90","author":"Horky","year":"1987","journal-title":"Exp Clin Endocrinol"},{"issue":"10","key":"2025081215532457800_dgaf290-B93","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/HYPERTENSIONAHA.123.21474","article-title":"Primary aldosteronism in chronic kidney disease: blood pressure control and kidney and cardiovascular outcomes after surgical versus medical management","volume":"80","author":"Cohen","year":"2023","journal-title":"Hypertension"},{"issue":"6","key":"2025081215532457800_dgaf290-B94","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/s41440-024-01648-0","article-title":"The effect of different treatment strategies on glycolipid metabolism disorders and cardiovascular events in primary aldosteronism","volume":"47","author":"Zhou","year":"2024","journal-title":"Hypertens Res"},{"issue":"10","key":"2025081215532457800_dgaf290-B95","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/HJH.0000000000003813","article-title":"Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry","volume":"42","author":"Araujo-Castro","year":"2024","journal-title":"J Hypertens"},{"issue":"1585","key":"2025081215532457800_dgaf290-B96","first-page":"73","article-title":"Increasing rates of referrals for investigation of primary aldosteronism at a tertiary centre","volume":"136","author":"Park","year":"2023","journal-title":"N Z Med J"},{"issue":"3","key":"2025081215532457800_dgaf290-B97","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HJH.0000000000003631","article-title":"Reversal of arterial stiffness in medically and surgically treated unilateral primary aldosteronism","volume":"42","author":"Chen","year":"2024","journal-title":"J Hypertens"},{"issue":"5","key":"2025081215532457800_dgaf290-B98","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jch.14810","article-title":"Surgical versus medical management of patients with primary hyperaldosteronism and indeterminate adrenal vein sampling: a 10-year experience of the Cleveland clinic","volume":"26","author":"Onwubueke","year":"2024","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"2025081215532457800_dgaf290-B99","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1210\/clinem\/dgaa080","article-title":"Effects of mineralocorticoid and AT1 receptor antagonism on the aldosterone-renin ratio in primary aldosteronism-the EMIRA study","volume":"105","author":"Rossi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025081215532457800_dgaf290-B100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4274\/BMJ.galenos.2022.2022.6-7","article-title":"Effect of the adrenalectomy and mineralocorticoid receptor antagonists on the clinical and biochemical outcomes in patients with primary aldosteronism: a single-center experience","volume":"18","author":"Turgut","year":"2022","journal-title":"Bakirkoy Tip Dergisi\/Med J Bakirkoy"},{"issue":"1","key":"2025081215532457800_dgaf290-B101","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12902-023-01281-x","article-title":"Significance of computed tomography combined with postural stimulation test in predicting laterality of primary aldosteronism","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"2025081215532457800_dgaf290-B102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3803\/EnM.2020.901","article-title":"Diagnostic accuracy of computed tomography in predicting primary aldosteronism subtype according to age","volume":"36","author":"Lee","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"5","key":"2025081215532457800_dgaf290-B103","doi-asserted-by":"crossref","first-page":"e2087","DOI":"10.1210\/clinem\/dgab047","article-title":"Adrenal venous sampling in young patients with primary aldosteronism. Extravagance or irreplaceable?","volume":"106","author":"Gkaniatsa","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025081215532457800_dgaf290-B104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jamasurg.2020.5011","article-title":"Association of adrenal venous sampling with outcomes in primary aldosteronism for unilateral adenomas","volume":"156","author":"Thiesmeyer","year":"2021","journal-title":"JAMA Surg"},{"issue":"2","key":"2025081215532457800_dgaf290-B105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/HJH.0000000000002634","article-title":"The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism","volume":"39","author":"Ma","year":"2021","journal-title":"J Hypertens"},{"issue":"1","key":"2025081215532457800_dgaf290-B106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1507\/endocrj.EJ20-0329","article-title":"Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism","volume":"68","author":"Wada","year":"2021","journal-title":"Endocr J"},{"issue":"3","key":"2025081215532457800_dgaf290-B107","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1210\/clinem\/dgz092","article-title":"Aldosterone reduction rate after saline infusion test may be a novel prediction in patients with primary aldosteronism","volume":"105","author":"Nagano","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025081215532457800_dgaf290-B108","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/a-0857-1620","article-title":"Evaluation of biochemical conditions allowing bypass of confirmatory testing in the workup of primary aldosteronism: a retrospective study in a French hypertensive population","volume":"51","author":"Vivien","year":"2019","journal-title":"Horm Metab Res"},{"issue":"7","key":"2025081215532457800_dgaf290-B109","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/js.2019-00131","article-title":"Lateralizing asymmetry of adrenal imaging and adrenal vein sampling in patients with primary aldosteronism","volume":"3","author":"Wada","year":"2019","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025081215532457800_dgaf290-B110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/HYPERTENSIONAHA.118.11382","article-title":"Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism","volume":"72","author":"Williams","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"2025081215532457800_dgaf290-B111","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1210\/jc.2017-01774","article-title":"Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism","volume":"103","author":"Umakoshi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025081215532457800_dgaf290-B112","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/jhh.2016.61","article-title":"Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism","volume":"31","author":"Kamemura","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"5","key":"2025081215532457800_dgaf290-B113","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"issue":"3","key":"2025081215532457800_dgaf290-B114","first-page":"414","article-title":"Diagnostic performance of multidetector computed tomography in distinguishing unilateral from bilateral abnormalities in primary hyperaldosteronism: comparison of multidetector computed tomography with adrenal vein sampling","volume":"39","author":"Raman","year":"2015","journal-title":"J Comput Assist Tomogr"},{"issue":"8","key":"2025081215532457800_dgaf290-B115","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025081215532457800_dgaf290-B116","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5152\/dir.2021.21215","article-title":"Adrenal venous sampling for stratifying patients for surgery of adrenal nodules detected using dynamic contrast enhanced CT","volume":"20","author":"Kim","year":"2014","journal-title":"Diagn Interv Radiol"},{"issue":"1","key":"2025081215532457800_dgaf290-B117","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jvir.2007.08.022","article-title":"Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?","volume":"19","author":"Zarnegar","year":"2008","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"2025081215532457800_dgaf290-B118","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00268-005-0622-8","article-title":"Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas","volume":"30","author":"Tan","year":"2006","journal-title":"World J Surg"},{"issue":"3","key":"2025081215532457800_dgaf290-B119","first-page":"1066","article-title":"Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism","volume":"86","author":"Magill","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025081215532457800_dgaf290-B120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiology.184.3.1509049","article-title":"Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT","volume":"184","author":"Doppman","year":"1992","journal-title":"Radiology"},{"issue":"2","key":"2025081215532457800_dgaf290-B121","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2214\/ajr.141.2.299","article-title":"Primary hyperaldosteronism: comparison of CT, adrenal venography, and venous sampling","volume":"141","author":"Geisinger","year":"1983","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2025081215532457800_dgaf290-B122","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3892\/etm.2024.12656","article-title":"Application value of adrenal venous sampling in the surgical treatment of primary aldosteronism","volume":"28","author":"Qiao","year":"2024","journal-title":"Exp Ther Med"},{"issue":"2","key":"2025081215532457800_dgaf290-B123","first-page":"839","article-title":"Diagnostic consistency between computed tomography and adrenal vein sampling of primary aldosteronism: leading to successful curative outcome after adrenalectomy; a retrospective study","volume":"110","author":"Kim","year":"2024","journal-title":"Int J Surg"},{"issue":"11","key":"2025081215532457800_dgaf290-B124","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/jch.14725","article-title":"Surgery based on computed tomography images might be feasible for primary aldosteronism patients with visible unilateral adenoma","volume":"25","author":"Fang","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"9","key":"2025081215532457800_dgaf290-B125","first-page":"246","article-title":"Clinical determinants of adrenal vein sampling success","volume":"18","author":"Berney","year":"2015","journal-title":"Kardiovaskulare Medizin"},{"issue":"1","key":"2025081215532457800_dgaf290-B126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.12809\/hkjr1413184","article-title":"Management of primary aldosteronism: should adrenal gland computed tomography be replaced by adrenal venous sampling?","volume":"17","author":"Lam","year":"2014","journal-title":"Hong Kong J Radiol"},{"issue":"9","key":"2025081215532457800_dgaf290-B127","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/HYPERTENSIONAHA.123.21096","article-title":"Association of reversal of renin suppression with long-term renal outcome in medically treated primary aldosteronism","volume":"80","author":"Katsuragawa","year":"2023","journal-title":"Hypertension"},{"issue":"1","key":"2025081215532457800_dgaf290-B128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41440-022-01045-5","article-title":"Importance of dietary salt restriction for patients with primary aldosteronism during treatment with mineralocorticoid receptor antagonists: the potential importance of post-treatment plasma renin levels","volume":"46","author":"Yoshida","year":"2023","journal-title":"Hypertens Res"},{"issue":"1","key":"2025081215532457800_dgaf290-B129","doi-asserted-by":"crossref","first-page":"bvab174","DOI":"10.1210\/jendso\/bvab174","article-title":"Increased dosage of MRA improves BP and urinary albumin excretion in primary aldosteronism with suppressed plasma renin","volume":"6","author":"Saiki","year":"2022","journal-title":"J Endocr Soc"},{"issue":"9","key":"2025081215532457800_dgaf290-B130","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41440-022-00960-x","article-title":"Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism","volume":"45","author":"Nomura","year":"2022","journal-title":"Hypertens Res"},{"issue":"1","key":"2025081215532457800_dgaf290-B131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40292-023-00618-w","article-title":"Renin as a biomarker to guide medical treatment in primary aldosteronism patients. Findings from the SPAIN-ALDO registry","volume":"31","author":"Parra Ramirez","year":"2024","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"12","key":"2025081215532457800_dgaf290-B132","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.eprac.2024.09.002","article-title":"Suppressed renin Status is a risk factor for cardiocerebrovascular events in bilateral primary aldosteronism treated with mineralocorticoid receptor antagonists","volume":"30","author":"Jiang","year":"2024","journal-title":"Endocr Pract"},{"issue":"4","key":"2025081215532457800_dgaf290-B133","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","article-title":"Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism","volume":"9","author":"Karagiannis","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"2025081215532457800_dgaf290-B134","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"issue":"3","key":"2025081215532457800_dgaf290-B135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/hr.2015.129","article-title":"Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism","volume":"39","author":"Karashima","year":"2016","journal-title":"Hypertens Res"},{"issue":"2","key":"2025081215532457800_dgaf290-B136","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.124.071452","article-title":"Efficacy and safety of finerenone in patients with primary aldosteronism: a pilot randomized controlled trial","volume":"151","author":"Hu","year":"2025","journal-title":"Circulation"},{"issue":"3","key":"2025081215532457800_dgaf290-B137","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41440-021-00836-6","article-title":"Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronism","volume":"45","author":"Ishikawa","year":"2022","journal-title":"Hypertens Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf290\/63724360\/dgaf290.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/e2833\/63724360\/dgaf290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/e2833\/63724360\/dgaf290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T19:53:48Z","timestamp":1755028428000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/9\/e2833\/8196230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":137,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,7,14]]},"published-print":{"date-parts":[[2025,8,7]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf290","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,7,14]]}}}